291 related articles for article (PubMed ID: 34888168)
21. A Negative Allosteric Modulator for α5 Subunit-Containing GABA Receptors Exerts a Rapid and Persistent Antidepressant-Like Action without the Side Effects of the NMDA Receptor Antagonist Ketamine in Mice.
Zanos P; Nelson ME; Highland JN; Krimmel SR; Georgiou P; Gould TD; Thompson SM
eNeuro; 2017; 4(1):. PubMed ID: 28275719
[TBL] [Abstract][Full Text] [Related]
22. The role of NMDA receptor in neurobiology and treatment of major depressive disorder: Evidence from translational research.
Amidfar M; Woelfer M; Réus GZ; Quevedo J; Walter M; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109668. PubMed ID: 31207274
[TBL] [Abstract][Full Text] [Related]
23. Agmatine as a potential therapeutic intervention in bipolar depression: the preclinical landscape.
Watts D; Pfaffenseller B; Wollenhaupt-Aguiar B; Paul Géa L; Cardoso TA; Kapczinski F
Expert Opin Ther Targets; 2019 Apr; 23(4):327-339. PubMed ID: 30764678
[TBL] [Abstract][Full Text] [Related]
24. [Resolvins as novel targets for rapid-acting antidepressants].
Deyama S
Nihon Yakurigaku Zasshi; 2020; 155(6):381-385. PubMed ID: 33132254
[TBL] [Abstract][Full Text] [Related]
25. Ketamine and the next generation of antidepressants with a rapid onset of action.
Machado-Vieira R; Salvadore G; Diazgranados N; Zarate CA
Pharmacol Ther; 2009 Aug; 123(2):143-50. PubMed ID: 19397926
[TBL] [Abstract][Full Text] [Related]
26. Rapid-Acting Antidepressants: Mechanistic Insights and Future Directions.
Gerhard DM; Duman RS
Curr Behav Neurosci Rep; 2018 Mar; 5(1):36-47. PubMed ID: 30034992
[TBL] [Abstract][Full Text] [Related]
27. Antidepressant and pro-neurogenic effects of agmatine in a mouse model of stress induced by chronic exposure to corticosterone.
Olescowicz G; Neis VB; Fraga DB; Rosa PB; Azevedo DP; Melleu FF; Brocardo PS; Gil-Mohapel J; Rodrigues ALS
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():395-407. PubMed ID: 28842257
[TBL] [Abstract][Full Text] [Related]
28. Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications?
Pellegrini C; Antonioli L; Calderone V; Colucci R; Fornai M; Blandizzi C
Prog Neurobiol; 2020 Aug; 191():101806. PubMed ID: 32473843
[TBL] [Abstract][Full Text] [Related]
29. Antidepressant-like effects of agmatine and NOS inhibitors in chronic unpredictable mild stress model of depression in rats: The involvement of NLRP inflammasomes.
Sahin Ozkartal C; Tuzun E; Kucukali CI; Ulusoy C; Giris M; Aricioglu F
Brain Res; 2019 Dec; 1725():146438. PubMed ID: 31518574
[TBL] [Abstract][Full Text] [Related]
30. The clinical antidepressant effect of exogenous agmatine is not reversed by parachlorophenylalanine: a pilot study.
Shopsin B
Acta Neuropsychiatr; 2013 Apr; 25(2):113-8. PubMed ID: 25287313
[TBL] [Abstract][Full Text] [Related]
31. The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine.
Monteggia LM; Gideons E; Kavalali ET
Biol Psychiatry; 2013 Jun; 73(12):1199-203. PubMed ID: 23062356
[TBL] [Abstract][Full Text] [Related]
32. Antidepressants induce autophagy dependent-NLRP3-inflammasome inhibition in Major depressive disorder.
Alcocer-Gómez E; Casas-Barquero N; Williams MR; Romero-Guillena SL; Cañadas-Lozano D; Bullón P; Sánchez-Alcazar JA; Navarro-Pando JM; Cordero MD
Pharmacol Res; 2017 Jul; 121():114-121. PubMed ID: 28465217
[TBL] [Abstract][Full Text] [Related]
33. Roles of glutamate signaling in preclinical and/or mechanistic models of depression.
Tokita K; Yamaji T; Hashimoto K
Pharmacol Biochem Behav; 2012 Feb; 100(4):688-704. PubMed ID: 21536063
[TBL] [Abstract][Full Text] [Related]
34. Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression.
Koike H; Iijima M; Chaki S
Behav Brain Res; 2011 Oct; 224(1):107-11. PubMed ID: 21669235
[TBL] [Abstract][Full Text] [Related]
35. mTORC1-dependent signaling pathway underlies the rapid effect of creatine and ketamine in the novelty-suppressed feeding test.
Pazini FL; Rosa JM; Camargo A; Fraga DB; Moretti M; Siteneski A; Rodrigues ALS
Chem Biol Interact; 2020 Dec; 332():109281. PubMed ID: 33022268
[TBL] [Abstract][Full Text] [Related]
36. Agmatine produces antidepressant-like effects by activating AMPA receptors and mTOR signaling.
Neis VB; Moretti M; Bettio LE; Ribeiro CM; Rosa PB; Gonçalves FM; Lopes MW; Leal RB; Rodrigues AL
Eur Neuropsychopharmacol; 2016 Jun; 26(6):959-71. PubMed ID: 27061850
[TBL] [Abstract][Full Text] [Related]
37. Agmatine potentiates antidepressant and synaptic actions of ketamine: Effects on dendritic arbors and spines architecture and Akt/S6 kinase signaling.
Freitas AE; Heinrich IA; Moura TM; Fraga DB; Costa AP; Azevedo D; Brocardo PS; Kaster MP; Leal RB; Rodrigues ALS
Exp Neurol; 2020 Nov; 333():113398. PubMed ID: 32659382
[TBL] [Abstract][Full Text] [Related]
38. What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities.
Strasburger SE; Bhimani PM; Kaabe JH; Krysiak JT; Nanchanatt DL; Nguyen TN; Pough KA; Prince TA; Ramsey NS; Savsani KH; Scandlen L; Cavaretta MJ; Raffa RB
J Clin Pharm Ther; 2017 Apr; 42(2):147-154. PubMed ID: 28111761
[TBL] [Abstract][Full Text] [Related]
39. The Microbiota-Inflammasome Hypothesis of Major Depression.
Inserra A; Rogers GB; Licinio J; Wong ML
Bioessays; 2018 Sep; 40(9):e1800027. PubMed ID: 30004130
[TBL] [Abstract][Full Text] [Related]
40. Rapid-acting antidepressants targeting modulation of the glutamatergic system: clinical and preclinical evidence and mechanisms.
Wang S; Tang S; Huang J; Chen H
Gen Psychiatr; 2022; 35(6):e100922. PubMed ID: 36605479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
